HFA Premium Access

Reaching the next level of drug development for heart failure: targetting mitochondria.

Topic: Cell Signalling
Organised by Charité Medical School Berlin, supported by an unrestricted educational grant from Stealth Peptides

Congress Presentation

About the speaker

Professor Stefan Anker

Charité - University Medicine Berlin, Berlin (Germany)
158 presentations
8 followers

3 more presentations in this session

Elamipretide improves mitochondrial activity in the failing human heart.

Speaker: Doctor B. Stauffer (Aurora, US)

Thumbnail

Elamipretide in heart failure with reduced ejection fraction.

Speaker: Professor H. Sabbah (Detroit, US)

Thumbnail

Clinical development concepts targeting mitochondria.

Speaker: Professor B. Pitt (Ann Arbor, US)

Thumbnail

Access the full session

Targeting mitochondria to improve outcomes in heart failure

Speakers: Professor S. Anker, Doctor B. Stauffer, Professor H. Sabbah, Professor B. Pitt
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb